Isocyanates and human health: Multistakeholder information needs and research priorities

Journal of Occupational and Environmental Medicine

Volumn 57, Issue 1, 2015, Pages 44-51

  Lockey, James E ^a   Redlich, Carrie A ^b   Streicher, Robert ^c   Pfahles Hutchens, Andrea ^d   Hakkinen, Pertti J ^e   Ellison, Gary L ^f   Harber, Philip ^g   Utell, Mark ^h   Holland, John ⁱ   Comai, Andrew ^j   White, Marc ^k  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

ⁱ Holland Assoc   (United States)

^j Health and Safety Department   (United States)

^k UNIVERSITY OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ISOCYANIC ACID DERIVATIVE;

AIR SAMPLING; ANIMAL MODEL; ARTICLE; CANCER RISK; CONSENSUS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HEALTH PRACTITIONER; HUMAN; MEDICAL INFORMATION; OCCUPATIONAL HEALTH; RESEARCH PRIORITY; RESPIRATORY TRACT DISEASE; SCIENTIST; SKIN TEST; TOXICITY TESTING; CHEMICALLY INDUCED; HEALTH CARE PLANNING; MEDICAL RESEARCH; NEOPLASM; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; ORGANIZATION; PROCEDURES; PRODUCT SAFETY;

ANIMALIA;

BIOMARKERS; BIOMEDICAL RESEARCH; CONGRESSES AS TOPIC; CONSENSUS; CONSUMER PRODUCT SAFETY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HEALTH PRIORITIES; HUMANS; ISOCYANATES; MODELS, ANIMAL; NEOPLASMS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HEALTH; RESPIRATORY TRACT DISEASES;

EID: 84921514747     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0000000000000278     Document Type: Article

References (30)

1. Allport DC, Gilbert DS, Outterside SM. MDI & TDI: Safety, Health and the Environment. West Sussex, England: John Wiley & Sons Ltd; 2003.
2. Redlich CA, Bello D, Wisnewski AV. Health effects of isocyanates. In: Environmental and Occupational Medicine. Philadelphia, PA: Lippincott-Raven Publishers; 2007:502-516.
3. Lesage J, Stanley J, Karoly WJ, Lichtenberg FW. Airborne methylene diphenyl diisocyanate (MDI) concentrations associated with the application of polyurethane spray foam in residential construction. J Occup Env Hyg. 2007;4:145-155.
4. Reeb-Whitaker C, Whittaker SG, Ceballos DM, et al. Airborne isocyanate exposures in the collision repair industry and a comparison to occupational exposure limits. J Occup Env Hyg. 2012;9:329-339.
5. Suojalehto H, Linstrom I, Henriks-Eckerman ML, Jungewelter S, Suuronen K. Occupational asthma related to low levels of airborne methylene diphenyl diisocyanate (MDI) in orthopedic casting work. Am J Ind Med. 2011;54: 906-910.
6. Wisnewski AV, Redlich CA, Mapp CE, Bernstein DI. Polyisocyanates and their prepolymers. In:Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, eds. Asthma in the Workplace. NY: Informa Healthcare; 2006:457-478.
7. Krone CA, Klingner TD. Isocyanates, polyurethane and childhood asthma. Pediatr Allergy Immunol. 2005;16:368-379.
8. Tsuang W, Huang YC. Asthma induced by exposure to spray polyurethane foam insulation in a residential home. J Occup Env Med. 2012:272-273.
9. Gylestam D, Riddar JB, Karlsson D, Dahlin J, Dalene M, Skarping G. Dry sampling of gas-phase isocyanates and isocyanate aerosols from thermal degradation of polyurethane. Ann Occup Hyg. 2014;58:28-49.
10. Vandenplas O. Occupational asthma: etiologies and risk factors. Allergy Asthma Immunol Res. 2011;3:157-167.
11. Bello D, Woskie SR, Streicher RP, et al. Polyisocyanates in occupational environments: a critical review of exposure limits and metrics. Am J Ind Med. 2004;46:480-491.
12. Bakerly ND, Moore VC, Vellore AD, Jaakkola MS, Robertson AS, Burge PS. Fifteen-year trends in occupational asthma: data from the Shield surveillance scheme. Occup Med. 2008;58:169-174.
13. Bernstein DI, Korbee L, Stauder T, et al. The low prevalence of occupational asthma and antibody-dependent sensitization to diphenylmethane diisocyanate in a plant engineered for minimal exposure to diisocyanates. J Allergy Clin Immunol. 1993;92:387-396.
14. Ott MG, Klees JE, Poche SL. Respiratory health surveillance in a toluene diisocyanate production unit, 1967-97: clinical observations and lung function analyses. Occup Environ Med. 2000;57:43-52.
15. White WG, Morris MJ, Sugden E, Zapata E. Isocyanate-induced asthma in a car factory. Lancet. 1980;1:756-760.
16. Woellner RC, Hall S, Greaves I, Schoenwetter WF. Epidemic of asthma in a wood products plant using methylene diphenyl diisocyanate. Am J Ind Med. 1997;31:56-63.
17. Petsonk EL, Wang ML, Lewis DM, Siegel PD, Husberg BJ. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest. 2000;118:1183-1193.
18. Baur X. Hypersensitivity pneumonitis (extrinsic allergic alveolitis) induced by isocyanates. J Allergy Clin Immunol. 1995;95:1004-1010.
19. Engfeldt M, Ponten A. Contact allergy to isocyanates after accidental spillage. Contact Dermat. 2013;69:122-124.
20. Bello D, Herrick CA, Smith TJ, et al. Skin exposure to isocyanates: reasons for concern. Env Health Perspect. 2007;115:328-335.
21. Redlich CA. Skin exposure and asthma: is there a connection? Proc Am Thorac Soc. 2010;7:134-137.
22. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemical to Humans. Re-evaluation of some organic chemicals, hydrazine and hydrogen peroxide. Lyon: WHO Press; 1999.
23. Prueitt RL, Rhomberg LR, Goodman JE. Hypothesis-based weight-ofevidence evaluation of the human carcinogenicity of toluene diisocyanate. Crit Rev Toxicol. 2013;43:391-435.
24. Labrecque M, Malo JL, Alaoui KM, Rabhi K. Medical surveillance programme for diisocyanate exposure. Occup Env Med. 2011;68:302-307.
25. Carlton GN, England EC. Exposures to 1,6-hexamethylene diisocyanate during polyurethane spray painting in the U.S. Air Force. Appl Occup Env Hyg. 2000;15:705-712.
26. Whittaker SG, Reeb-Whitaker C. Characterizing the health and safety needs of the collision repair industry. J Occup Env Hyg. 2009;6:273-282.
27. Bakke JE, Olof Noren J, Thorud S, Aasen TB, eds. International Consensus Report on Isocyanates-Risk Assessment and Management. Norway: Hotel Norge Hoesbjoer; 2001.
28. Cocker JE. Biological monitoring for isocyanates. Ann Occup Hyg. 2011;55:127-131.
29. Sabbioni G, Gu Q, Vanimireddy LR. Determination of isocyanate specific albumin-adducts in workers exposed to toluene diisocyanates. Biomarkers. 2012;17:150-159.
30. Wisnewski AV, Stowe MH, Nerlinger A, et al. Biomonitoring hexamethylene diisocyanate (HDI) exposure based on serum levels of HDI-specific IgG. Ann Occup Hyg. 2012;56:901-910.